Shaanxi Kanghui Pharm Co Ltd Asset Resilience Ratio

Latest as of March 2026: 0.01%

Shaanxi Kanghui Pharm Co Ltd asset resilience ratio. Shaanxi Kanghui Pharm Co Ltd (603139) has an Asset Resilience Ratio of 0.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 603139 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥252.20K
≈ $36.90K USD Cash + Short-term Investments

Total Assets

CN¥1.71 Billion
≈ $249.51 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Shaanxi Kanghui Pharm Co Ltd (2019–2025)

Asset resilience ratio of Shaanxi Kanghui Pharm Co Ltd from 2019 to 2025. This chart shows how Shaanxi Kanghui Pharm Co Ltd's Asset Resilience Ratio has changed over time. Read 603139 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shaanxi Kanghui Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shaanxi Kanghui Pharm Co Ltd total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥252.20K 0.01%
Total Liquid Assets CN¥252.20K 0.01%

Asset Resilience Insights

  • Limited Liquidity: Shaanxi Kanghui Pharm Co Ltd maintains only 0.01% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shaanxi Kanghui Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shaanxi Kanghui Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Ajanta Pharma Limited
NSE:AJANTPHARM
Drug Manufacturers - Specialty & Generic 14.99%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
Drug Manufacturers - Specialty & Generic 26.45%
Porton Fine Chemicals Ltd
SHE:300363
Drug Manufacturers - Specialty & Generic 6.85%
Jubilant Pharmova Limited
NSE:JUBLPHARMA
Drug Manufacturers - Specialty & Generic 1.26%

Shaanxi Kanghui Pharm Co Ltd Asset Resilience Ratio by Year (2019–2025)

Shaanxi Kanghui Pharm Co Ltd asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Shaanxi Kanghui Pharm Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.01% CN¥252.20K
≈ $36.90K
CN¥1.81 Billion
≈ $265.51 Million
-0.01pp
2024-12-31 0.02% CN¥359.18K
≈ $52.56K
CN¥1.89 Billion
≈ $276.25 Million
-0.13pp
2023-12-31 0.15% CN¥3.02 Million
≈ $441.85K
CN¥2.05 Billion
≈ $300.23 Million
-0.10pp
2022-12-31 0.25% CN¥4.50 Million
≈ $658.73K
CN¥1.82 Billion
≈ $266.57 Million
-6.18pp
2021-12-31 6.42% CN¥119.47 Million
≈ $17.48 Million
CN¥1.86 Billion
≈ $272.21 Million
+2.19pp
2020-12-31 4.23% CN¥55.47 Million
≈ $8.12 Million
CN¥1.31 Billion
≈ $191.87 Million
-12.75pp
2019-12-31 16.98% CN¥192.00 Million
≈ $28.10 Million
CN¥1.13 Billion
≈ $165.45 Million
--
pp = percentage points

About Shaanxi Kanghui Pharm Co Ltd

SHG:603139 China Drug Manufacturers - Specialty & Generic
Market Cap
$426.19 Million
CN¥2.91 Billion CNY
Market Cap Rank
#12714 Global
#3730 in China
Share Price
CN¥29.16
Change (1 day)
-1.62%
52-Week Range
CN¥20.27 - CN¥45.21
All Time High
CN¥45.21
About

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates in China. It is involved in the research, development, production, and sale of traditional Chinese medicine preparations; research and development of prepared slices of Chinese medicinal herbs and pharmaceutical intermediates; and pharmaceutical distribution of biolo… Read more